Home Subscriber Only GenoPalate completes $4 million funding round

GenoPalate completes $4 million funding round

By
Andrew Weiland
-
Sherry Zhang
GenoPalate founder and CEO Sherry Zhang Credit: Jake Hill

Wauwatosa-based GenoPalate, Inc., an early-stage nutritional genomics company, announced that it has completed a $4 million round of equity financing from local investors. This is the third round of funding for the company. The funds will be used to expand the capacity of GenoPalate’s internet platform, which the company says will more than double its

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now
  • Critical Milwaukee and Southeastern Wisconsin business news and analysis updated daily.
  • 16 issues per year delivered in print or digitally
  • Unlimited access to all insider only content on our website, on any device.
  • Free email alerts.
  • Extra bonus issues (STUFF and Giving Guide)
  • Discounted in-person event registration

Click here to purchase a sharable paywall bypass link for this subscriber-only article.

Andrew Weiland
Andrew is the editor of BizTimes Milwaukee. He joined BizTimes in 2003, serving as managing editor and real estate reporter for 11 years before being promoted to editor in 2015. An award-winning journalist, Weiland is a five-time winner in the Milwaukee Press Club Excellence in Journalism Awards contest and a three-time winner in the Alliance of Area Business Publishers (AABP) Awards contest. He is also a regular guest on WISN-TV Channel 12's 4 p.m. newscast to discuss the week's most significant business news stories.
Linkedin Mail Twitter

RELATED ARTICLES

Copyright ©2025 BizTimes Media, LLC. All Rights Reserved.
Wauwatosa-based GenoPalate, Inc., an early-stage nutritional genomics company, announced that it has completed a $4 million round of equity financing from local investors. This is the third round of funding for the company. The funds will be used to expand the capacity of GenoPalate’s internet platform, which the company says will more than double its current capacity. GenoPalate is a provider of nutrigenomics testing and analytical services to help consumers make healthy dietary choices. Using proprietary algorithms, GenoPalate interprets the customer’s DNA to help determine a personalized nutrition profile that shows them which foods are good and bad for their health. In addition to internet platform development, the funds will be used to expand digital marketing and to continue the development of research databases for addressing personalized nutrition, health and wellness, and chronic metabolic diseases such as type-2 diabetes, obesity, and metabolic syndrome, the company said. “To truly eat healthy and apply daily food behavior to preventing chronic metabolic diseases, one must personalize his or her nutrition. Genomics is key to our understanding of anyone's food personalization for health,” said chief executive officer Sherry Zhang, a geneticist who founded GenoPalate in 2016.

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.

Exit mobile version